BRIEF-Haleon To Sell NRT Business Outside Of U.S. To Dr Reddy's

Reuters06-26

June 26 (Reuters) - HALEON PLC :

* HALEON PLC - DIVESTMENT OF NRT BUSINESS OUTSIDE OF THE US

* HALEON PLC: TO SELL ITS NICOTINE REPLACEMENT THERAPY ("NRT") BUSINESS OUTSIDE OF US TO DR. REDDY'S LABORATORIES SA

* HALEON PLC - CONSIDERATION OF £500 MILLION IS STRUCTURED AS AN UPFRONT CASH PAYMENT OF £458 MILLION

* HALEON PLC - PROPOSED DEAL FOR TOTAL CONSIDERATION OF £500 MILLION

* HALEON PLC: ALL OTHER FY 2024 GUIDANCE AS SHARED IN Q1 TRADING STATEMENT ON 1 MAY 2024 IS UNCHANGED

* HALEON PLC - DIVESTMENT WILL ALLOW HALEON TO EXIT NRT CATEGORY OUTSIDE OF US

* HALEON: ASSUMING COMPLETION OF DEAL IN EARLY Q4, SALE EXPECTED TO DILUTE FY 2024 NET REVENUE, ADJUSTED OPERATING PROFIT BY C. 0.5% AND C. 1% RESPECTIVELY

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2446364164?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-26 19:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446364164","market":"us","top_or_hot":-1,"title":"BRIEF-Haleon To Sell NRT Business Outside Of U.S. To Dr Reddy's","media":"Reuters","content":"<html><body><p>June 26 (Reuters) - <a href=\"https://laohu8.com/S/HLNCF\">HALEON PLC</a>   :</p><p>   * <a href=\"https://laohu8.com/S/HLN.UK\">HALEON PLC</a>  - DIVESTMENT OF NRT BUSINESS OUTSIDE OF THE US</p><p>   * HALEON <a href=\"https://laohu8.com/S/PLC\">PLC</a>: TO SELL ITS NICOTINE REPLACEMENT THERAPY (\"NRT\") BUSINESS OUTSIDE OF US TO DR. REDDY'S LABORATORIES SA</p><p>   * HALEON PLC - CONSIDERATION OF £500 MILLION IS STRUCTURED AS AN UPFRONT CASH PAYMENT OF £458 MILLION</p><p>   * HALEON PLC - PROPOSED DEAL FOR TOTAL CONSIDERATION OF £500 MILLION</p><p>   * HALEON PLC: ALL OTHER FY 2024 GUIDANCE AS SHARED IN Q1 TRADING STATEMENT ON 1 MAY 2024 IS UNCHANGED</p><p>   * HALEON PLC - DIVESTMENT WILL ALLOW HALEON TO EXIT NRT CATEGORY OUTSIDE OF US</p><p>   * HALEON: ASSUMING COMPLETION OF DEAL IN EARLY Q4, SALE EXPECTED TO DILUTE FY 2024 NET REVENUE, ADJUSTED OPERATING PROFIT BY C. 0.5% AND C. 1% RESPECTIVELY</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Haleon To Sell NRT Business Outside Of U.S. To Dr Reddy's</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Haleon To Sell NRT Business Outside Of U.S. To Dr Reddy's\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-26 19:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>June 26 (Reuters) - HALEON PLC   :   * HALEON PLC  - DIVESTMENT OF NRT BUSINESS OUTSIDE OF THE US   * HALEON PLC: TO SELL ITS NICOTINE REPLACEMENT THERAPY (\"NRT\") BUSINESS OUTSIDE OF US TO DR. REDDY'S...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HLN","symbol_name":"Haleon","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2446364164","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446364164","pubTimestamp":1719402820,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"June 26  - HALEON PLC   :   * HALEON PLC  - DIVESTMENT OF NRT BUSINESS OUTSIDE OF THE US   * HALEON PLC: TO SELL ITS NICOTINE REPLACEMENT THERAPY  BUSINESS OUTSIDE OF US TO DR. REDDY'S LABORATORIES SA   * HALEON PLC - CONSIDERATION OF 500 MILLION IS STRUCTURED AS AN UPFRONT CASH PAYMENT OF 458 MILLION   * HALEON PLC - PROPOSED DEAL FOR TOTAL CONSIDERATION OF 500 MILLION   * HALEON PLC: ALL OTHER FY 2024 GUIDANCE AS SHARED IN Q1 TRADING STATEMENT ON 1 MAY 2024 IS UNCHANGED   * HALEON PLC - DIVESTMENT WILL ALLOW HALEON TO EXIT NRT CATEGORY OUTSIDE OF US   * HALEON: ASSUMING COMPLETION OF DEAL IN EARLY Q4, SALE EXPECTED TO DILUTE FY 2024 NET REVENUE, ADJUSTED OPERATING PROFIT BY C. 0.5% AND C. 1% RESPECTIVELYSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HLN":"Haleon","BK4213":"石油与天然气的勘探与生产","NRT":"北欧皇家石油信托","BK4183":"个人用品"},"translate_title":"简报-Haleon将把美国以外的NRT业务出售给Dr Reddy's","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLN":1,"NRT":1},"content_text":"June 26 (Reuters) - HALEON PLC   :   * HALEON PLC  - DIVESTMENT OF NRT BUSINESS OUTSIDE OF THE US   * HALEON PLC: TO SELL ITS NICOTINE REPLACEMENT THERAPY (\"NRT\") BUSINESS OUTSIDE OF US TO DR. REDDY'S LABORATORIES SA   * HALEON PLC - CONSIDERATION OF £500 MILLION IS STRUCTURED AS AN UPFRONT CASH PAYMENT OF £458 MILLION   * HALEON PLC - PROPOSED DEAL FOR TOTAL CONSIDERATION OF £500 MILLION   * HALEON PLC: ALL OTHER FY 2024 GUIDANCE AS SHARED IN Q1 TRADING STATEMENT ON 1 MAY 2024 IS UNCHANGED   * HALEON PLC - DIVESTMENT WILL ALLOW HALEON TO EXIT NRT CATEGORY OUTSIDE OF US   * HALEON: ASSUMING COMPLETION OF DEAL IN EARLY Q4, SALE EXPECTED TO DILUTE FY 2024 NET REVENUE, ADJUSTED OPERATING PROFIT BY C. 0.5% AND C. 1% RESPECTIVELYSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446364164"}